Post on 19-Jan-2016
Seminar 1
2011 Fast Track
Probiotics limit the severity of post weaning diarrhoea
Larissa Beale
About me
• Graduated Bach App. Sci. (1st class Hons) from Uni QLD
• Interest is in developing new strategies to help combat disease and improve animal husbandry
Background
• PWD causes significant loss to producers
• A multi factorial disease with ETEC playing a major role
• Past prevention regimes relied on antimicrobials
• Decreased effectiveness of antimicrobial based techniques due to resistance
• Increased need for alternative management strategies
Probiotic design
• E. coli formula tailor made to be effective against O141, O149 and O157
• Screened over 25 000 E. coli sourced from different pig samples
• Tested for their antagonism, survivability and safety
Project aim
• Test the efficacy of an E. coli probiotic formula to help combat ETEC associated PWD
Experimental design
• 12 gilts and their offspring– 6 probiotic supplement and 6 control
Betty
Flow of water
Control gilts Probiotic treated gilts
Blocked Door
Access Door
Experimental design
• 12 gilts and their offspring– 6 probiotic supplement and 6 control
• Dosage rate of 1x109 CFU E. coli probiotic formula (in a dextrose base)
• Dextrose base only (control/placebo)
• Given orally via syringe
Betty
• Probiotic or placebo received orally at birth, 5 days of age and the day prior to weaning
• 60 piglets randomly allocated to challenge group
• ETEC (5x109 CFU) challenge received orally at weaning for 3 consecutive days
Blocked Door
Access Door
Hospital Pen
Challenge Room
Flow of water
Record keeping
• Individual faecal consistency was recorded daily for 4 days after weaning
• Scores 1 or 2 were considered as ‘normal’ and 3 – 5 as ‘scouring’
Faecal consistency scores
1 – Dry, pelleted faeces
2 – Moulded faeces
3 – Moist, cow dung appearance
4 – Diarrhoea
5 – Watery diarrhoea
Results• Record of every faecal consistency score
• Control animals had fewer scores of 1 and more at 5
• Majority probiotic animals had scores of 2
Faecal S
core
Days post-weaning
Scouring
Not Scouring
• All the consistency scores were added and averaged for each animal
• Average faecal consistency for probiotic supplemented animals was not a scouring level
45% 3%97%55%
Commercial significance
• The E. coli probiotic successfully reduced the severity and duration of PWD
• Currently being tested under commercial conditions at a number of sites
Acknowledgements
• Co authors: H.J.M Brouwers, B. Turner, D. Jordan, R. Al Jassim and T.A. Chapman
• Pork CRC, International Animal Health Products
• EMAI staff and students
Seminar 2
2011 Fast Track
Effect of dietary nano chromium picolinate on growth carcass
characteristics, and insulin sensitivity in pigs
Supervisors: Prof. Frank Dunshea, Assoc. Prof. Brian Leury, Dr. Matthew Sabin
Tsung-Yu Hung (Alex)
• B. Animal science-Chinese Culture University (Taiwan)
• Animal nutrition specialist. Swine feed & nutrition Division –Great Wall Enterprise CO. LTD. (Taiwan)
• M. Phil (Animal Feed &Nutrition)-National Chiayi University (Taiwan)
• Research assistant /Laboratory manager- Animal Nutrition Lab. Department of Animal science. National Chiayi University. (Taiwan)
• PhD (Animal production)-Melbourne University
Personal background
Benefit of Cr in farm animals
• Growth performance - ADG ↑ (average daily weight gain )
- FCR ↑ (Feed conversion rate)
• Carcass trait - P2 backfat ↓
- longissimus muscle ↑
• Meat quality - marbling scores ↑
- water holding capacity ↑
• Stress
• Poor absorption of Cr - 0.5 to 3% inorganic form of Cr can be absorbed
-< 20% organic form of Cr can be absorbed
Why Nano Cr?
What is nano?
10-9 or 1/1,000,000,000.
Prolong compound residence time
Increase surface area
Improve solubility
Why Nano size particle can improve the absorption of nutrient
Net change (kg/day) P-value
Con vs Nano 0.03 (n=8) 0.02
Con vs Normal 0.001 (n=6) 0.63
Normal vs Nano 0.04 (n=6) <0.01
Net change of ADG (kg/day)
-0.1 0.0 0.1 0.2 0.3 0.4
Wang & Xu (2004)
Wang et. al. (2007)
Wang et. al. (2009a)
Wang et. al (2009b)
Hung et. al (2009) (low fat)
Hung et. al (2009) (high fat)
Li & Lien (2010) (CrPic)
Li & Lien (2010) (CrCl)
NanoNormalNet change in ADG
Nano-Cr Nano-Cr increases ADGincreases ADG
(Hung et al. 2010)
Net change (feed/gain) P-value
Con vs Nano -0.086 (n=8) <0.01
Con vs Normal -0.015 (n=6) 0.17
Normal vs Nano -0.005 (n=6) 0.73
Net change of FCR (feed/gain)
-0.5 -0.4 -0.3 -0.2 -0.1 0.0 0.1 0.2 0.3
Wang & Xu (2004)
Wang et. al. (2007)
Wang et. al. (2009a)
Wang et. al (2009b)
Hung et. al (2009) (low fat)
Hung et. al (2009) (high fat)
Li & Lien (2010) (CrPic)
Li & Lien (2010) (CrCl)
Nano NormalNet change in
FCR
Nano-Cr improves Nano-Cr improves FCRFCR
(Hung et al. 2010)
Net change (cm) P-value
Con vs Nano -0.049 (n=7) 0.02
Con vs Normal -0.01 (n=5) <0.01
Normal vs Nano -0.01 (n=5) 0.57
Net change of backfat (cm)
-0.7 -0.6 -0.5 -0.4 -0.3 -0.2 -0.1 0.0
Wang & Xu (2004)
Wang et. al. (2007)
Wang et. al (2009b)
Hung et. al (2009) (low fat)
Hung et. al (2009) (high fat)
Li & Lien (2010) (CrPic)
Li & Lien (2010) (CrCl)
Nano Normal
Net change in backfat
Nano-Cr decreases Nano-Cr decreases backfatbackfat
(Hung et al. 2010)
Digestibility of nano-Cr in pig
control CrCl3 Nano-CrCl3 CrPic Nano-CrPic
%
30
40
50
60
31.1%
10.7%
Nano Cr improved Cr digestibility
(Li & Lien 2010)
Nano-Cr Increases Nano-Cr Increases digestibility of Crdigestibility of Cr
Cr picolinate
1st stage2.0 mm grinding bead
NanoCr (< 100 nm)2nd stage0.3 mm grinding bead
Micro Cr (<20 μm)
Preparation of nano-Cr
Normal Cr (<1mm)
SEM image of nano-Cr
50 μM
50 μM
ab
a ab
HF vs. LF (P<O.05)Control vs. Cr (P<0.05)
Nano-Cr improve ADG
kg
P2 backfat Control vs. Cr (P<0.01)
mm
bab
a a
Carcass weightControl vs. Cr (P<0.01)
kg
bab ab
a
b
abab
a
Muscle depthControl vs. Cr (P<0.05)Control vs. Cr on HF diet (P<0.05)
Nano-Cr decreases P2 backfat and increase carcass weight and muscle depth
Control vs. Cr (P<0.05)
Nano-Cr improves insulin sensitivity
Nano Cr up-regulated adiponectin mRNA expression in adipose tissue
Nano-Cr improved Insulin signaling gene expression in muscle
Conclusion
• Dietary nano-CrPic supplementation can increase ADG, carcass weight, and reduce P2 backfat.
• Dietary nano-CrPic supplementation can improve insulin sensitivity by increasing insulin signaling gene expression.
Acknowledgements
Seminar 3
2011 Fast Track
Determining the lysine requirements of pigs immunised
against GnRF
Karen Moore
WA Dept. of Agriculture & Food
Boar taint
• Entire male production
• Urine or perspiration odour/flavour
• Boar taint compounds - androstenone and skatole
• Significant cause of consumer complaints
• Sensitivity to boar taint increasing
2011
D’Souza et al. 2011
Eliminating boar taint
• Castration is the only effective method
– Physical – perceived welfare issues
– Immunological (Improvac®)• Used by at least 25% of Australian industry• Nearly 60 countries worldwide
– Brazil, China, USA and Canada
Improvac blocks the reproductive hormones
Pituitary
No LH & FSH
Androstenone decreases
Skatole decreases
Testes
XHypothalamus anti-GnRFGnRF
0.0
0.1
0.2
0.3
0.4
0.5
0.0 0.5 1.0 1.5 2.0 2.5
Androstenone (µg/g fat)
Ska
tole
(µ
g/g
fat)
Entire
Improvac
Improvac® - no more boar taint
Dunshea et al. (unpublished)
(D’Souza et al., 1999)
Castration and Eating Quality
Boars Improvac® Castrates
Aroma 56a 62b 62b
Flavour 58 66 62
Tenderness 52a 62b 59b
Juiciness 60 64 59
Overall acceptability
58a 67b 62a
0 = dislike extremely; 100 = like extremely
• Production of immunised males is associated with
• Deterioration in feed conversion• Increased P2
• No published work on lysine requirements.• It can have a big influence on cost of diets and
hence profitability• It can have a big impact on growth and carcass
quality if it is not correct• All other amino acids are supplied as a ratio to
lysine
But…..
Aims
• To determine the available lysine/MJ digestible energy ratio of immunised males and how this compares with entire males
• To determine how the lysine requirement changes after the second vaccination
Daily gain
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
0.2 0.3 0.4 0.5 0.6 0.7 0.8
Available lysine:DE
Dai
ly g
ain
(kg
/day
)
Entire males
Immunised males
60 to 108 kg LW
Average:Entires – 1.09
Immuno – 1.20
Moore et al. (unpublished)
2.0
2.2
2.4
2.6
2.8
3.0
3.2
0.2 0.3 0.4 0.5 0.6 0.7 0.8
Available lysine:DE
Fe
ed
:Ga
in
Entire males
Immunised males
Feed to gain
60 to 108 kg LW
Average:Entires – 2.51
Immuno – 2.58
Moore et al. (unpublished)
Feed intake
2.0
2.2
2.4
2.6
2.8
3.0
3.2
3.4
0.2 0.3 0.4 0.5 0.6 0.7 0.8
Available lysine:DE
Fee
d i
nta
ke (
kg/d
ay)
Entire males
Immunised males
60 to 108 kg LWMoore et al. (unpublished)
Backfat
8
9
10
11
12
13
14
15
16
0.2 0.3 0.4 0.5 0.6 0.7 0.8
Available lysine:DE
P2
(mm
)
Entire males
Immunised males
Moore et al. (unpublished)
Summary
• Immunised males vs. entire males
• Increased daily gain• Increased feed intake• Increased feed to gain• Lower Av Lys:DE requirement• Increased backfat• Increased carcase weight• Lower dressing percentage
Established and supported under the Australian
Government’s Cooperative Research Centres Program
Feed intake over time
1.5
2.0
2.5
3.0
3.5
4.0
7 14 21 28 35 42
Days after vaccination
Fe
ed
inta
ke
(k
g/d
ay
)
Entire males
Immunisedmales
Moore et al. (unpublished)
Daily gain over time
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
7 14 21 28 35 42
Days after vaccination
Dai
ly g
ain
(kg/
day)
Entire male
Immunised male
Moore et al. (unpublished)
Feed to gain over time
2.02.12.22.32.42.52.62.72.82.93.0
7 14 21 28 35 42
Days after vaccination
Fee
d:G
ain
Entire male
Immunised male
Moore et al. (unpublished)
What does this mean for you?
• Boar taint is still an issue– one method to effectively control it is the use of Improvac®
• Lysine requirements will be different depending on your situation
– these values provide a standard– talk to your nutritionist to determine optimum lysine
requirement for your genotype and environment
• Suggested feeding regime – feed as for entire males until at least 2 weeks after
vaccination when the lysine requirement can be decreased
Where to next?
• Investigate physiological and carcase composition changes that occur following the second vaccination of Improvac®
• Overall goal:– Identify management strategies that can be easily
implemented to minimise the increase in backfat and decrease in feed efficiency associated with the production of pigs immunised against GnRF